Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...
Prostate-specific membrane antigen (PSMA) is highly overexpressed in most prostate cancers and is clinically visualized using PSMA-specific probes incorporating glutamate-ureido-lysine (GUL). PSMA is ...
A new way to prevent excruciating pain from the side effects of advanced prostate cancer therapy has been developed.Many men ...
Scientists at The Wistar Institute in Philadelphia have developed a new immunotherapeutic strategy to treat cancer using synthetic DNA to directly encode protective antibodies against a ...
A new prostate cancer "homing device" could improve detection and allow for the first targeted treatment of the disease. A team of Purdue University researchers has synthesized a molecule that finds ...
Subsequent treatment with APC8015F and its effect on survival in the control arm of phase III sipuleucel-t studies. Background: Prostate-specific membrane antigen (PSMA), a type II transmembrane ...
Dr Jeremie Calais reviews the VISION trial and the implications of the data in the treatment paradigm for metastatic castration-resistant prostate cancer (mCRPC). Alicia Morgans, MD: I am curious from ...
Jeremie Calais, MD, comments on how PSMA PET scans have changed the treatment landscape for patients with mCRPC and describes the process for obtaining a PSMA PET scan, including what patients should ...
Prostate-specific membrane antigen (PSMA) is a transmembrane glycoprotein found on the cell membrane. PSMA is specifically and highly expressed in prostate cancer (PCa). Its expression level is also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback